US2018282781A1PendingUtilityA1
Acoustic radiation for ejecting and monitoring pathogenic fluids
Est. expiryJul 18, 2022(expired)· nominal 20-yr term from priority
C40B 60/14C12Q 1/22B01J 2219/00362B01L 3/0268B01L 3/508C40B 40/10C40B 40/06B01J 2219/00378B01L 2400/0436B01J 2219/00725B01L 3/0293B01J 2219/00659B01L 2200/0647B01J 2219/00722
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to methods and devices that use focused radiation to handle and/or monitor pathogenic fluids. In particular, a method is provided for dispensing one or more droplets of a fluid containing a pathogen. The method involves providing the pathogen-containing fluid in a reservoir and applying focused radiation to the pathogen-containing fluid in the reservoir in a manner effective to eject a droplet of the fluid therefrom. Often, a pathogen-impermeable enclosure is used.
Claims
exact text as granted — not AI-modified1 .- 42 . (canceled)
43 . A method for detecting for an interaction between a fluid and a compound, wherein the fluid and/or compound are pathogenic, comprising:
(a) providing a reservoir containing the fluid; (b) depositing the compound onto a designated site on a surface of a substrate; (c) positioning the substrate so that the designated site is in droplet-receiving relationship with respect to the reservoir; (d) applying focused radiation to the fluid in the reservoir in a manner effective to eject a droplet of the fluid therefrom onto the substrate surface at the designated site; (e) sealing the fluid droplet and the compound at the designated site in a pathogen-impermeable enclosure; and (f) detecting for an interaction between the fluid and the compound.
44 . The method of claim 43 , wherein the compound is pathogenic.
45 . The method of claim 43 , wherein the fluid is pathogenic.
46 . The method of claim 43 , wherein the interaction is acoustically detected.
47 . The method of claim 43 , wherein the interaction is optically detected.
48 . The method of claim 43 , wherein the interaction is fluorescently detected.
49 . The method of claim 43 , wherein the interaction is magnetically detected.
50 . The method of claim 43 , wherein the interaction is electrically detected.
51 . The method of claim 43 , further comprising, after (e), (e′) subjecting the pathogen-impermeable enclosure to temperatures associated with PCR thermal cycling.
52 .- 53 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.